Prof. Dr. med. Arndt Hartmann

Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie

Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial (2025) Bergmann L, Albiges L, Ahrens M, Gross-Goupil M, Boleti E, Gravis G, Fléchon A, et al. Journal article Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer (2025) Gloßner L, Eckstein M, Mark C, Beckmann M, Hartmann A, Strissel P, Strick R Journal article Mast cells infiltrates are common in eosinophilic esophagitis and still elevated in histological remission: A digital evaluation in children (2025) Hironimus T, Degen S, Rappl A, Allabauer I, Wölfle J, Hartmann A, Bruns V, et al. Journal article Peniskarzinom: Die Bedeutung der histologischen Klassifikation und neue Behandlungsansätze (2025) Fiegl A, Mink JN, Junker K, Linxweiler J, Hartmann A Journal article, Review article Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer (2024) Fasching P, Hu C, Hart SN, Rübner M, Polley EC, Gnanaolivu RD, Hartkopf AD, et al. Journal article Impairment of α-tubulin and F-actin interactions of GJB3 induces aneuploidy in urothelial cells and promotes bladder cancer cell invasion (2024) Liu J, Wang X, Jiang W, Azoitei A, Eiseler T, Eckstein M, Hartmann A, et al. Journal article Towards interactive AI-authoring with prototypical few-shot classifiers in histopathology (2024) Kuritcyn P, Kletzander R, Eisenberg S, Wittenberg T, Bruns V, Evert K, Keil F, et al. Journal article The Role of Microsatellite Instability/DNA Mismatch Repair Deficiency and Tumor Mutational Burden as Biomarkers in Predicting Response to Immunotherapy in Castration-resistant Prostate Cancer (2024) Klümper N, Grünwald V, Hartmann A, Hölzel M, Eckstein M Journal article Warum Tumoren der Harnblase? (2024) Gaisa NT, Hartmann A Journal article Prognosis prediction with the IHC3 score in patients with node-negative, hormone receptor-positive, HER2-negative early breast cancer (2024) Seitz K, Goossens C, Hübner H, Gaß P, Uhrig S, Heindl F, Emons J, et al. Journal article